Abstract
The effect of monoaminergic agents on RCBF, negative symptoms, and cognitive performance in schizophrenia : D. Daniel, N. Breslin, J. Clardy, A. Abi-Dargham, S. Handel, T. Goldberg, J. Gold, C. Randolph, L. Bigelow, K. Berman, M. Linnoila, J. Kleinman, D. Weinberger NIMH Neuroscience Center at Saint Elizabeths, Washington, DC 20032
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
